Ajaya was founded by Mohit S. in 2024.

Who are Ajaya's investors?

Ajaya's investors include The Innovation Space, Ben Franklin Technology Partners.

How much funding has Ajaya raised?

Ajaya has disclosed $150K raised across 1 of its 2 known rounds.

Where is Ajaya headquartered?

Ajaya is headquartered in Philadelphia, US.

Ajaya

Philadelphia, US · Founded 2024 · Delaware corporation · 4 employees on LinkedIn · 6 known investors

Find your way into Ajaya

Paths you didn't know you had: your email and LinkedIn already hold routes to the Ajaya team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ajaya Bio develops bispecific therapies designed to eliminate disease-driving cells while sparing healthy ones, using its BOLT-360 discovery platform built around hybrid binders, precise activation, and advanced linkers. The company operates in the biotherapeutics field.

Biotech Deep Tech

Founders & leadership

Ajaya was founded in 2024 by Mohit S..

Mohit S.FounderMohit S. has 15+ years of experience in immunology, oncology, and genetic medicine, including leadership roles at Orion, Cellectis, Interius, and Spark Therapeutics, with publications and patent filings in the field. He founded Ajaya Bio to develop bispecific therapies for autoimmune diseases and cancer.

Investors · 6

The Innovation Spacelisted by The Innovation SpaceWilmington · $200K

How we know: The Innovation Space's portfolio page · Not right? Tell us

Ben Franklin Technology PartnersreportedHarrisburg · $50K – $250K

How we know: technical.ly · Not right? Tell us

Also in the syndicate · 4

BioAdvance CapitalFreeflow VenturesleadRK Family TrustleadTangent Advisorslead

Reported raises · per SEC filings

Form D private placements

$150K disclosed across 1 of 2 rounds · 2024–2026

▶$150KraisedJul 2024 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Mohit SachdevaExecutive Officer, Director

Offering amount: $300K
Amount sold: $150K
First sale: Apr 2024
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Ideaya BiosciencesIDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers. Its lead candidate, darovasertib, is in late-stage trials for uveal melanoma, with a pipeline spanning PKC inhibition, ADC+DDR combinations, the MTAP pathway, and KAT6/7 inhibition.

Companies working in the same space as Ajaya.

Frequently asked questions

What does Ajaya do?: Ajaya Bio develops bispecific therapies designed to eliminate disease-driving cells while sparing healthy ones, using its BOLT-360 discovery platform built around hybrid binders, precise activation, and advanced linkers. The company operates in the biotherapeutics field.
Who founded Ajaya?: Ajaya was founded by Mohit S. in 2024.
Who are Ajaya's investors?: Ajaya's investors include The Innovation Space, Ben Franklin Technology Partners.
How much funding has Ajaya raised?: Ajaya has disclosed $150K raised across 1 of its 2 known rounds.
Where is Ajaya headquartered?: Ajaya is headquartered in Philadelphia, US.